IMMUPHARMA PLC — Major Shareholding Notification 2018

Feb 9, 2018

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 4832E

Immupharma PLC

09 February 2018

9 February 2018

ImmuPharma PLC

("ImmuPharma" or the "Company")

Holding in Company

ImmuPharma PLC (LSE: IMM), the specialist drug discovery and development company, announces that on 8 February 2018 it received notification that Alto Invest no longer holds a notifiable interest in the Company.  

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) 596/2014.

For further information, please contact:

ImmuPharma plc (www.immupharma.com) Tim McCarthy, Chairman Lisa Baderoon, Head of Investor Relations lisa.baderoon@immupharma.com	+44 (0) 207 152 4080 +44 (0) 7721 413 496
Northland Capital Partners Limited David Hignell, Jamie Sportswood (Corporate Finance) Rob Rees (Corporate Broking)	+44 (0) 203 861 6625

This information is provided by RNS

The company news service from the London Stock Exchange

END

HOLXKLFBVLFZBBK